Lingying Wu

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆

Xiaohua Wu, Jianqing Zhu, Rutie Yin et al. · Annals of Oncology · 2021 · 206 citations

Medicine, Oncology, Pharmacology +15

Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer

Ning Li, Jianqing Zhu, Rutie Yin et al. · JAMA Oncology · 2023 · 159 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model

Leilei Liang, Jing Yu, Ning Li et al. · Frontiers in Oncology · 2021 · 142 citations · Full text

Life Sciences, Cell Biology, Oncology +17

ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription

Leilei Liang, Yunshu Zhu, Jian Li et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 120 citations · Full text

Medicine, Cancer Biology, Oncology +17

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients

Xiaohua Wu, Lingying Wu, Beihua Kong et al. · International Journal of Gynecological Cancer · 2017 · 119 citations

Medicine, Gynecology, Oncology +17